Cite
Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial
MLA
Jean-Luc Faucheron, et al. Sphincter-Saving Surgery after Neoadjuvant Therapy for Ultra-Low Rectal Cancer Where Abdominoperineal Resection Was Indicated: 10-Year Results of the GRECCAR 1 Trial. Jan. 2021. EBSCOhost, https://doi.org/10.1093/bjs/znaa010⟩.
APA
Jean-Luc Faucheron, Philippe Rouanet, Laurent Bresler, Denis Pezet, L. Mineur, M. Jafari, C Lemanski, Jacques Balosso, Marc Pocard, B Lelong, E. Rullier, J M Fabre, François Dravet, Michel Rivoire, & Sophie Gourgou. (2021). Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial. https://doi.org/10.1093/bjs/znaa010⟩
Chicago
Jean-Luc Faucheron, Philippe Rouanet, Laurent Bresler, Denis Pezet, L. Mineur, M. Jafari, C Lemanski, et al. 2021. “Sphincter-Saving Surgery after Neoadjuvant Therapy for Ultra-Low Rectal Cancer Where Abdominoperineal Resection Was Indicated: 10-Year Results of the GRECCAR 1 Trial,” January. doi:10.1093/bjs/znaa010⟩.